Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion

Journal of the American College of Cardiology

Volumn 30, Issue 3, 1997, Pages 682-688

  Mandinov, Lazar ^a   Kaufmann, Philipp ^a   Staub, Daniel ^a   Buckingham, Thomas A ^a   Amann, Franz Wolfgang ^a   Hess, Otto Martin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; VASOMOTOR REFLEX;

EID: 0030883890     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00212-X     Document Type: Review

References (38)

1. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty a quantitative arteriographic analysis . Circulation. 78:1988;1323-1334.
2. Fischell TA, Nellessen U, Johnson DE, Ginsburg R. Endothelium-dependent arterial vasoconstriction after balloon angioplasty. Circulation. 79:1989;899-910.
3. El Tamimi H, Davies GJ, Hackett D, et al. Abnormal vasomotor changes early after coronary angioplasty a quantitative arteriographic study of their time course . Circulation. 84:1991;1198-1202.
4. Fischell TA, Bausback KN, McDonald TV. Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty. J Clin Invest. 86:1990;575-584.
5. Leung WH. Coronary vasoconstriction after angioplasty of total occlusions relation to change in coronary perfusion pressure . J Am Coll Cardiol. 22:1993;1635-1640.
6. Gregorini L, Fajadet J, Robert G, Cassagneau B, Bernis M, Marco J. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation. 90:1994;895-907.
7. Ameli S, Kaul S, Castro L, Arora C, Mirea A, Shah PK. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels. Am J Cardiol. 72:1993;1352-1356.
8. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med. 330:1994;523-528.
9. Ciabattoni G, Ujang S, Sritara P, et al. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. J Am Coll Cardiol. 21:1993;1377-1381.
10. Braden GA, Knapp HR, FitzGerald GA. Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin. Circulation. 84:1991;679-685.
11. Tousoulis D, Davies G, Tentolouris C, Apostolopoulos T, Kyriakides M, Toutouzas P. Effects of ketanserin on epicardial coronary arteries after coronary angioplasty in patients with stable angina. Eur Heart J. 15:1994;922-927.
12. Maguire JJ, Bacon CR, Fujimoto M, Davenport AP. Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors. J Hypertens. 12:1994;675-680.
13. Berti F, Rossoni G, Della BD, et al. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol. 22:1993;321-326.
14. Yao SK, Ober JC, Krishnaswami A, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 86:1992;1302-1309.
15. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
16. Cooke JP, Rossitch EJ, Andon NA, Loscalzo J, Dau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 88:1991;1663-1671.
17. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 5:1985;587-592.
18. Buchi M, Hess OM, Kirkeeide RL, et al. Validation of a new automatic system for biplane quantitative coronary arteriography. Int J Card Imaging. 5:1990;93-103.
19. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 85:1992;1899-1911.
20. Sudhir K, Hargrave VK, Johnson EL, et al. Measurement of volumetric coronary blood flow with a Doppler catheter validation in an animal model . Am Heart J. 124:1992;870-875.
21. Yamagishi M, Hotta D, Tamai J, Nakatani S, Miyatake K. Validity of catheter-tip Doppler technique in assessment of coronary flow velocity and application of spectrum analysis method. Am J Cardiol. 67:1991;758-762.
22. Di Mario C, Meneveau N, Gil R, et al. Maximal blood flow velocity in severe coronary stenoses measured with a Doppler guidewire limitations for the application of the continuity equation in the assessment of stenosis severity . Am J Cardiol. 71:1993;54D-61D.
23. Brown B, Bolson E, Dodge H. Dynamic mechanisms in human coronary stenosis. Circulation. 70:1984;917-922.
24. Fischell TA. Coronary artery spasm after percutaneous transluminal coronary angioplasty pathophysiology and clinical consequences . Cathet Cardiovasc Diagn. 19:1990;1-3.
25. McFadden EP, Bauters C, Lablanche JM, Quandalle P, Leroy F, Bertrand ME. Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation. 88:1993;2076-2085.
26. Brum JM, Sufan Q, Lane G, Bove AA. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation. 70:1984;1066-1073.
27. Lamping KG, Marcus ML, Dole WP. Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res. 57:1985;46-54.
28. Lam JY, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation. 75:1987;243-248.
29. Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 61:1987;256-270.
30. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 336:1990;897-900.
31. Cragg A, Einzig S, Castaneda ZW, Amplatz K, White JG, Rao GH. Vessel wall arachidonate metabolism after angioplasty possible mediators of postangioplasty vasospasm . Am J Cardiol. 51:1983;1441-1445.
32. Cohen RA, Zitnay KM, Weisbrod RM. Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res. 61:1987;829-833.
33. Cannan CR, Burnett JJ, Brandt RR, Lerman A. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 92:1995;3312-3317.
34. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow an endothelium-dependent mechanism that fails in patients with atherosclerosis . J Am Coll Cardiol. 16:1990;349-356.
35. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation. 80:1989;466-474.
36. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
37. Bertrand ME, Lablanche JM, Fourrier JL, Gommeaux A, Ruel M. Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment. Am J Cardiol. 63:1989;277-281.
38. McClellan G, Weisberg A, Rose D, Winegard S. Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res. 75:1994;85-96.